Status:
UNKNOWN
Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression Disorder
Lead Sponsor:
Huashan Hospital
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
16-55 years
Brief Summary
Early improvemrnt, decreased 20% in the 17 items of Hamilton Depression Rating Scale (HAMD-17) at the second week of the treatment of major depression disorder (MDD), can arguably predict the remissio...
Eligibility Criteria
Inclusion
- right-handed; HAMD-17 more than 17; diagnosed with MDD by the Structured Clinical Interview for DSM-IV
Exclusion
- patients diagnosed with other condition in DSM-IV Axis I; pregnency; Thyroid disease; Heart Disease
Key Trial Info
Start Date :
July 25 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 11 2018
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03230682
Start Date
July 25 2017
End Date
July 11 2018
Last Update
July 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Neurology, Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, China, 200040